Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HeartFlowHTFL +5.99%12 Cash-to-Debt is 6.01 as of Mar. 2026, which is 691% above its 10-year median of 0.76. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 670 Healthcare Providers & Services companies, HeartFlow ranks better than 76.27% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. HeartFlow's cash to debt ratio for the quarter that ended in Mar. 2026 was 6.01.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, HeartFlowcould pay off its debt using the cash in hand for the quarter that ended in Mar. 2026.
The historical rank and industry rank for HeartFlow's Cash-to-Debt or its related term are showing as below:
HTFL'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32 Med: 0.76 Max: 13.36
Current: 6.01
During the past 3 years, HeartFlow's highest Cash to Debt Ratio was 13.36. The lowest was 0.32. And the median was 0.76.
HTFL's Cash-to-Debt is ranked better than 76.27% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 0.79
vs HTFL: 6.01
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
HeartFlow Cash-to-Debt Related Terms
HeartFlow Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for HeartFlow's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Health Information Services subindustry, HeartFlow's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartFlow Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HeartFlow's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where HeartFlow's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeartFlow (HTFL) has a Cash-to-Debt of 6.01 as of Mar. 2026. This is 691% above median its historical median of 0.76. Over the past decade, HeartFlow's Cash-to-Debt has ranged from 0.32 to 13.36. According to the industry distribution chart, HeartFlow ranks #159 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 23.7%.
Is HeartFlow's Cash-to-Debt too high?
HeartFlow's current Cash-to-Debt of 6.01 is 691% above median its 10-year median of 0.76. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 13.36. The Healthcare Providers & Services industry median Cash-to-Debt is 0.79. HeartFlow's value of 6.01 is 660.8% above this industry median. Based on the distribution chart, HeartFlow ranks #159 out of 670 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Cash-to-Debt compare to OMCL and TDOC?
According to the Healthcare Providers & Services industry distribution chart, HeartFlow ranks #159 out of 670 companies for Cash-to-Debt. This places HeartFlow in the top 24% of its industry — outperforming the majority of peers. The industry median Cash-to-Debt is 0.79. HeartFlow's value of 6.01 is 660.8% above this benchmark. Historically, HeartFlow's own Cash-to-Debt has ranged from 0.32 to 13.36 over the past decade. While the company's 10-year median is 0.76 vs. the industry median of 0.79, HeartFlow has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.79, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HeartFlow's current Cash-to-Debt of 6.01 is 660.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartFlow's current Cash-to-Debt is 6.01, which is 691% above median its own 10-year median of 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Cash-to-Debt of 6.01. The current Cash-to-Debt is 6.01, which is 691% above median its 10-year median of 0.76 and 660.8% above the Healthcare Providers & Services industry median of 0.79. HeartFlow's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For HeartFlow (HTFL), the current Cash-to-Debt is 6.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score
Get the complete analysis for HTFL
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HTFL has been successfully added to your 
